Home DNA Damage/DNA Repair DNA/RNA Synthesis modulator Lurbinectedin For research use only.

Lurbinectedin

Synonyms: PM-1183, LY-01017, Tryptamicidin, PM01183

Lurbinectedin, a DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activity. Lurbinectedin inhibits RMG1 and RMG2 cell growth with IC50 of 1.25 nM and 1.16 nM, respectively.

Lurbinectedin Chemical Structure

Lurbinectedin Chemical Structure

CAS: 497871-47-3

Purity & Quality Control

Batch: Purity: 99.93%
99.93

Other DNA/RNA Synthesis Products

Related compound libraries

Choose Selective DNA/RNA Synthesis Inhibitors

Biological Activity

Description Lurbinectedin, a DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activity. Lurbinectedin inhibits RMG1 and RMG2 cell growth with IC50 of 1.25 nM and 1.16 nM, respectively.
Targets
DNA minor groove [1] RMG2 cell growth [1]
(Cell-based assay)		 RMG1 cell growth [1]
(Cell-based assay)
1.16 nM 1.25 nM
In vitro
In vitro

Lurbinectedin exhibits significant antitumor activity toward chemosensitive and chemoresistant CCC cells in vitro. Lurbinectedin plus SN-38 combination has strong synergistic effects on both the cisplatin-resistant and paclitaxel-resistant CCC cell lines.[1]
Cell Research Cell lines The human ovarian CCC cell lines (RMG1, RMG2, KOC7C, HAC2)
Concentrations 0.1 nM, 0.3 nM, 1 nM, 3 nM
Incubation Time 48 h
Method

CCC cells (2~5×105) are treated with lurbinectedin, SN38 or in combination of the two drugs at the indicated concentrations for 48 hours. Then, the cells are harvested and stained with PI and annexin V using the annexin V-fluorescein isothiocyanate (FITC) apoptosis detection kit, according to the manufacturer's instructions. Fluorescence data are collected using flow cytometry. The sum total of early apoptotic cells (annexin V(+), PI(−) cells) and late apoptotic cells (annexin V(+), PI(+) cells) is defined as the total number of apoptotic cells. The experiments are repeated at least three times.
In Vivo
In vivo

An examination of mouse CCC cell xenografts reveals that lurbinectedin significantly inhibits tumor growth. Lurbinectedin plus SN-38 combination results in a significant synergistic effect. Everolimus significantly enhances the antitumor activity of lurbinectedin-based chemotherapies.[1]
Animal Research Animal Models 5- to 7-week-old nude mice
Dosages 0.180 mg/kg
Administration IV
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06088290 Recruiting Leiomyosarcoma PharmaMar September 21 2023 Phase 2|Phase 3
NCT05734066 Recruiting Refractory Ewing Sarcoma|Relapsed Ewing Sarcoma|Ewing Sarcoma Jazz Pharmaceuticals May 23 2023 Phase 1|Phase 2
NCT05244239 Recruiting Extensive Stage Lung Small Cell Carcinoma|Stage IV Lung Cancer AJCC v8 Emory University|National Cancer Institute (NCI)|Jazz Pharmaceuticals July 27 2022 Phase 1
NCT05285033 Completed Small-cell Lung Cancer Intergroupe Francophone de Cancerologie Thoracique|Groupe Français de Pneumo-Cancérologie|PharmaMar April 1 2022 --

Chemical lnformation & Solubility

Molecular Weight 784.87 Formula

C41H44N4O10S
CAS No. 497871-47-3 SDF --
Smiles CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=C(CCN8)C2=C(N9)C=CC(=C2)OC)OCO7)C)OC(=O)C)C(=C1OC)O
Storage (From the date of receipt) 3 years -20°C powder

In vitro
Batch:


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lurbinectedin | Lurbinectedin supplier | purchase Lurbinectedin | Lurbinectedin cost | Lurbinectedin manufacturer | order Lurbinectedin | Lurbinectedin distributor